Webinar Personalised Health: From science to market
Are you interested in developing evidence-based personalised health applications in your business to contribute to a healthier society? Get inspired by the experience of companies that already innovate with us. Join our interactive webinar for the latest scientific based developments in personalised health.
- Startdatum:
- Time:
- 15:00 - (CET)
- Location:
-
Online
- Costs:
-
Free
Let's prevent or revert lifestyle-related diseases
Public health is declining due to the increase in chronic lifestyle-related diseases. These diseases can be prevented and even reversed. However, this requires a sustainable behaviour change to be successful.
Within the Personalised Health research programme, TNO has developed new knowledge, innovative methodologies and tools to provide personalised health advice. The measurement of so-called phenotypic flexibility (challenge tests) was pioneered by TNO and still constitutes the starting point for personalised health advice. But it’s not just biology that matters. Psychology, behaviour and social context are also taken into account in order to develop the best tools and interventions for the individual. TNO’s vision on public health improvement is that a systems approach is needed, from measuring health to supporting healthy behaviour.
Putting personalised health into practice
Together with various partners, we are committed to translating our acquired knowledge into applications and to putting personalised health into practice. We help partners and companies with:
- Sense: Selecting the right (objective) and science-based measurements by assessing a person’s health status from a 360 degrees perspective;
- Reason: Making use of a science-based model that translates data from a person’s situation into the optimal personalised lifestyle intervention and;
- Act: Based on a person’s personality, behaviour, preferences and circumstances determine the right lifestyle support for a sustainable behaviour change to maintain health and prevent or revert lifestyle-related diseases.
If you want to learn how, we warmly invite you to join our interactive webinar for the latest scientific insights in personalised health and get inspired by the experience of companies that already innovate with us.
This webinar answers these questions:
- What are the latest scientific developments for putting personalised health into practice?
- How to come to evidence-based personalised health products and services?
- What are the latest trends and developments in the market of personalised health?
“Personalised health and lifestyle interventions taking into account your own biology, phenotypic flexibility, personality and preferences is there to stay! As applied research organisation, we help other parties how to bring these personalised health innovations, scientific understanding and consumer engagement into applications and products that help create a healthy society.”
Programme
Introduction
By webinar host Nard Clabbers, thought leader in personalised nutrition.
Science
- Sarah Berry | Opening lecture: Personalised nutrition for metabolic health
- Suzan Wopereis, TNO | From science to evidence based personalised health applications and services.
Market
Three companies pitch their (future) product/service:
- MixMasters: Tom Geleijnse (CEO)
- Ancora Health: Sridhar Kumaraswamy (CEO)
- J&J Consumer Health: Gabriele Ronnett, PhD, MD (Head of Nutritional Therapeutics & Systems Health) | Let’s take it personally
-
Round table discussion & questions
Keynote: In pursuit of Personalised nutrition - the solution on our plates.
Mariette Abrahams, PhD, MBA (CEO Qina).
Wrap up
Nard Clabbers.
Speakers
Watch the webinar
- The webinar takes place on 21 March 2023 from 15:00-16:30 CET.
- Not able to join live? We will share the recording afterwards.
- This webinar will be held in English.
"My research focuses on the influence of dietary components on cardiometabolic disease risk; personalised nutrition, postprandial lipid metabolism and food and fat structure."
"In this next phase, we will see the personlised nutrition industry coming of age. It is not only exciting, it will actually make a difference."
Contact us
-
Wim van Hartingsveldt
Functie:Business Development Manager-
Standplaats:Leiden - Sylviusweg
-
Telefoon:+31 88 866 17 30
-
Email:Email Wim
-
-
Suzan Wopereis
Function not knownMy main research focus is studying on the understanding of what biological mechanisms drive health, how you can measure health and deviations from health and importantly on how to intervene on an individual level with lifestyle on health (personalised health).
-
Standplaats:Leiden - Sylviusweg
-
Telefoon:+31 88 866 50 13
-
Email:Email Suzan
-
LinkedIn:Suzan on LinkedIn
-
Get inspired
Public Private Partnership supports intestinal health in early life
Public Private Partnership Fontanelle works on the solutions that contribute to long-term effects on (gut) health through the development of an integrated approach of in vitro, ex vivo and AI models to test the potential health benefits of specialised nutrition for infants and young piglets.
Personalised food conveniently delivered to your home
MixMasters develops, manufactures, and packages personalised health food and sports supplements. They try to bring healthy food to their customers in innovative ways and focus mainly on the sports and health industry.
TNO's view of 2030: 50% reduction in lifestyle-related diseases
We look ahead to 2030 and find out, among other things, how we can offer people a healthy environment and with a healthier lifestyle.
Personalised Lifestyle and Resilience
Behavioural change is the key to curing lifestyle diseases. In short: lifestyle as medicine. Find out more about our innovations and tools.
Cash infusion for photonics-focused biosensor start-up
Biosensor R&D start-up Delta Diagnostics has received a seed investment from two leading innovators: research organization TNO – The Netherlands Organization for Applied Scientific Research – and PhotonDelta, an ecosystem of photonic chip technology organizations. This investment enables Delta Diagnostics to further develop and validate its biosensor systems in preparation for a Series A investment round later this year.
